Location History:
- Belmont, CA (US) (1997)
- San Anselmo, CA (US) (2016 - 2019)
- Novato, CA (US) (2019 - 2023)
- Fairfax, CA (US) (2023)
Company Filing History:
9 out of 135 
2 out of 3,539 
2 out of 282 
Years Active: 1997-2025
Title: Inventor Spotlight: Peter Cameron Colosi
Introduction
Peter Cameron Colosi is a distinguished inventor based in Novato, California. With an impressive portfolio of 12 patents, Colosi has made significant contributions to the field of biomedical engineering, particularly in gene therapy and viral vector design.
Latest Patents
Colosi’s recent innovations include the development of adeno-associated virus (AAV) Factor VIII vectors. This invention presents improved AAV FVIII vectors that effectively produce a functional Factor VIII polypeptide, along with AAV FVIII vectors demonstrating high expression activity. Additionally, he has developed liver-targeting adeno-associated viral vectors that incorporate novel AAV capsid proteins. These innovations involve AAV particles comprising these new capsid proteins, as well as polynucleotides encoding them, which have considerable therapeutic potential.
Career Highlights
Throughout his career, Peter Colosi has been associated with reputable organizations. Notably, he has worked with BioMarin Pharmaceutical Inc. and the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. His work within these institutions has been pivotal in advancing research and development in gene therapy applications.
Collaborations
Colosi has collaborated with influential professionals in his field, including Amit Nathwani and Jenny McIntosh. These partnerships have enhanced the innovative processes behind his inventions, contributing to collective knowledge and advancements in patient care and treatment methodologies.
Conclusion
Peter Cameron Colosi stands out as a remarkable inventor whose work is shaping the future of biomedical innovations. With a solid foundation of patents and strong collaborations, his contributions continue to push the boundaries of medical science and offer new hope in therapeutic solutions.